At a glance
ClinicalIndex Comparison RecordN/ACompleted· 107 enrolled
Drug / intervention
Inactivated H1N1 vaccine +1 morebiological
Likely dose
Inactivated H1N1 vaccine 0.5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Effect of Age and Priming on the Immunological Response to an Inactivated Vaccine for Novel H1N1 Virus.
In Brief
A clinical study evaluating Inactivated H1N1 vaccine for Influenza. Completed, enrolled 107 participants across 1 site.
Detailed Summary
The purpose of this study is to describe the immune response to a novel H1N1 influenza vaccination in healthy adults, and to understand the factors that allow healthy adults to respond to a single dose of vaccine even if they have never previously experience novel H1N1 disease or vaccination.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedDec 2009
Primary CompletionNov 2010
Study CompletionJul 2011
TodayJul 2026
First PostedDec 2, 2009
Enrollment StartNov 1, 2009
Primary CompletionNov 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.6 years ago
Interventions
Inactivated H1N1 vaccinebiological
0.5 ml IM into Deltoid region of arm
Inactivated H1N1 vaccinebiological
0.5 mL IM X 1 dose